E-LIB Suche - Ergebnisse für: Barbour, April M.

1

Effect of Hepatic Impairment on the Pharmacokinetics of Ita..:

Barbour, April M. ; Rockich, Kevin ; Cimino, Evan...
The Journal of Clinical Pharmacology. 61 (2021) 7 - p. 954-960 , 2021

Link: https://doi.org/10.1002/..

2

The Effect of Renal Impairment on the Pharmacokinetics and ..:

Srinivas, Nithya ; Barbour, April M. ; Epstein, Noam...
The Journal of Clinical Pharmacology. 60 (2020) 8 - p. 1022-1029 , 2020

Link: https://doi.org/10.1002/..

3

Evaluation of Clinical Cardiac Safety of Itacitinib, a JAK1..:

Gong, Xiaohua ; Darpo, Borje ; Xue, Hongqi...
Clinical Pharmacology in Drug Development. 9 (2019) 6 - p. 677-688 , 2019

Link: https://doi.org/10.1002/..

4

Effect of Itraconazole or Rifampin on Itacitinib Pharmacoki..:

Barbour, April M. ; Punwani, Naresh ; Epstein, Noam...
The Journal of Clinical Pharmacology. 59 (2019) 12 - p. 1641-1647 , 2019

Link: https://doi.org/10.1002/..

5

Antibiotics Development and the Emergence of Resistance: Cl..:

Upreti, Vijay V. ; Barbour, April M.
The Journal of Clinical Pharmacology. 58 (2018) 4 - p. 409-411 , 2018

Link: https://doi.org/10.1002/..

6

Infusions Are the Optimal Dosing Method in Intravenous ADME..:

Barbour, April M. ; Fossler, Michael J.
The Journal of Clinical Pharmacology. 58 (2017) 1 - p. 25-28 , 2017

Link: https://doi.org/10.1002/..

7

Single‐dose euglycaemic clamp studies demonstrating pharmac..:

Crutchlow, Michael F. ; Palcza, John S. ; Mostoller, Kate M....
Diabetes, Obesity and Metabolism. 20 (2017) 2 - p. 400-408 , 2017

Link: https://doi.org/10.1111/..

8

Utility of concentration-effect modeling and simulation in ..:

Barbour, April M. ; Magee, Mindy ; Shaddinger, Bonnie...
The Journal of Clinical Pharmacology. 55 (2015) 6 - p. 661-670 , 2015

Link: https://doi.org/10.1002/..

9

Application of pharmacokinetic/pharmacodynamic modelling an..:

Barbour, April M. ; Schmidt, Stephan ; Zhuang, Luning..
International Journal of Antimicrobial Agents. 43 (2014) 1 - p. 60-67 , 2014

Link: https://doi.org/10.1016/..

10

Practical Considerations for Dose Selection in Pediatric Pa..:

Barbour, April M. ; Fossler, Michael J. ; Barrett, Jeffrey
The AAPS Journal. 16 (2014) 4 - p. 749-755 , 2014

Link: https://doi.org/10.1208/..

11

Novel fusion of GLP-1 with a domain antibody to serum album..:

Bao, Weike ; Holt, Lucy J ; Prince, Rob D...
Cardiovascular Diabetology. 12 (2013) 1 - p. 148 , 2013

Link: https://doi.org/10.1186/..

12

Population pharmacokinetic modeling and simulation of ampre..:

Barbour, April M. ; Gibiansky, Leonid ; Wire, Mary Beth
The Journal of Clinical Pharmacology. 54 (2013) 2 - p. 206-214 , 2013

Link: https://doi.org/10.1002/..

13

Safety, tolerability, pharmacokinetics and pharmacodynamics..:

Barbour, April M. ; Sarov-Blat, Lea ; Cai, Gengqian...
British Journal of Clinical Pharmacology. 76 (2013) 1 - p. 99-106 , 2013

Link: https://doi.org/10.1111/..

14

Single‐dose euglycaemic clamp studies demonstrating pharmac..:

Crutchlow, Michael F ; Palcza, John S ; Mostoller, Kate M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813203/. , 2017

Link: http://www.ncbi.nlm.nih...

15

Practical Considerations for Dose Selection in Pediatric Pa..:

Barbour, April M ; Fossler, Michael J ; Barrett, Jeffrey
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070253/. , 2014

Link: http://www.ncbi.nlm.nih...